Back

VDJdive and ECLIPSE enhance single-cell TCR sequencing analysis through the probabilistic resolution of ambiguous clonotypes

Burns, E. C.; Movassagh, M.; Lundell, J. F.; Ye, M.; Ye, Z.; Oliveira, G.; Rout, R.; Hugaboom, M. B.; Street, K.; Braun, D. A.

2026-02-20 immunology
10.64898/2026.02.18.706444 bioRxiv
Show abstract

Single-cell T cell receptor sequencing (scTCR-seq) has transformed our ability to track individual T cell clones and has been instrumental in advancing our understanding of human T cell differentiation. However, current computational pipelines for analysis, which require precise matching of CDR3 sequences from exactly 2 heterodimeric TCR chains to define the clonotype for each cell, are inherently limited because of the substantial proportion of cells possessing "ambiguous" clonotypes driven by missing (undetected from the technical issue of chain "dropout") or extra chains (present from either true biological expression or due to technical artifacts such as cellular doublets and ambient TCR contamination). As a result, clone sizes are artificially reduced, impeding the tracking of clones across conditions and differentiation states. Here we introduce VDJdive and ECLIPSE (Enhanced CLonotypic Inference via Prediction of Single-cell Expression), two computational methods that, together, resolve this clonal ambiguity by utilizing the expectation-maximization algorithm for the clonal prediction of ambiguous cells. These methods consider chain pairings across the sample, allowing for high-fidelity prediction of chains lost due to dropout and the discernment of biological expression of extra chains from technical artifacts. Consequently, clone sizes are augmented and cells without clonotype assignments are minimized. Our approach facilitates enhanced clonal tracking through these elevated clone sizes and is easily implementable, compatible with standard single-cell transcriptomic workflows, and broadly applicable across biological contexts and T cell subsets.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Nature Methods
336 papers in training set
Top 0.6%
14.0%
2
Nature Biotechnology
147 papers in training set
Top 0.7%
9.8%
3
Bioinformatics
1061 papers in training set
Top 4%
7.0%
4
Nature Computational Science
50 papers in training set
Top 0.1%
6.2%
5
Genome Medicine
154 papers in training set
Top 1%
6.2%
6
Cell Systems
167 papers in training set
Top 2%
6.2%
7
eLife
5422 papers in training set
Top 18%
4.7%
50% of probability mass above
8
Nucleic Acids Research
1128 papers in training set
Top 5%
4.2%
9
Nature Communications
4913 papers in training set
Top 41%
3.5%
10
iScience
1063 papers in training set
Top 7%
2.8%
11
PLOS Computational Biology
1633 papers in training set
Top 12%
2.5%
12
Genome Biology
555 papers in training set
Top 3%
2.3%
13
Frontiers in Immunology
586 papers in training set
Top 4%
1.6%
14
Cell Reports Medicine
140 papers in training set
Top 4%
1.6%
15
Nature
575 papers in training set
Top 11%
1.6%
16
Cell Reports
1338 papers in training set
Top 26%
1.4%
17
Genome Research
409 papers in training set
Top 3%
1.3%
18
PLOS ONE
4510 papers in training set
Top 59%
1.3%
19
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 38%
1.2%
20
BMC Bioinformatics
383 papers in training set
Top 6%
1.2%
21
Scientific Reports
3102 papers in training set
Top 72%
0.9%
22
Communications Biology
886 papers in training set
Top 20%
0.9%
23
Cell
370 papers in training set
Top 16%
0.8%
24
Bioinformatics Advances
184 papers in training set
Top 5%
0.8%
25
Nature Immunology
71 papers in training set
Top 2%
0.8%
26
NAR Genomics and Bioinformatics
214 papers in training set
Top 4%
0.7%
27
Life Science Alliance
263 papers in training set
Top 2%
0.7%
28
Nature Medicine
117 papers in training set
Top 5%
0.7%
29
Science
429 papers in training set
Top 21%
0.7%
30
Journal of Cell Biology
333 papers in training set
Top 5%
0.6%